The American Cannabis Operator Index added on to its 30.8% gain in January, rising 4.2% to 105.31 in February:

The index, which launched at the end of October with a value of 100, traded as low as 70.64 in late December after having reached a closing high of 124.16 in early November and has now rebounded 49.1% from the December 24th low:

During February, the index included 22 companies, including 17 multi-state operators (MSOs) and 5 focused solely on CBD extracted from industrial hemp. Several MSOs are pursuing CBD strategies apart from their state-licensed cannabis businesses.  7 companies managed double-digit gains, while 4 posted double-digit losses:

The three best performers included Chicago-based MSOs Cresco Labs (CSE: CL) (OTC: CRLBF) and Green Thumb Industries (CSE: GTII) (OTC: GTBIF) along with Curaleaf Holdings (CSE: CURA) (OTC: CURLF). MedMen Enterprises (CSE: MMEN) (OTC: MMNFF) led the way lower, and several companies focused on CBD from industrial hemp weighed on the index as well, including CV Sciences (OTC:CVSI), Isodiol International (CSE: ISOL) (OTC: ISOLF) and Charlotte’s Web (CSE: CWEB) (OTC: CWBHF)

For March, the index will include 23 names, as Cannex Holdings (CSE: CNNX) (OTC: CNXXF), Dixie Brands (CSE: DIXI) (OTC: DXBRF) and Halo Labs (NEO: HALO) (OTC: AGEEF),  enter for the first time.  We also removed GB Sciences (OTC: GBLX) due the decline in quarterly sales below the $1 million minimum and Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF) due the decline in price below the $0.10 minimum.

In the next monthly review, we will summarize the performance for March and discuss any additions or deletions. Be sure to bookmark the page to stay current on American cannabis operators stock price movements within the day or from day-to-day.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email